DNA strand breaks are a prerequisite for many cancer-associated genomic alterations, including amplifications, deletions, inversions, and structural rearrangements. High-throughput technologies that measure genome-wide DNA quantities, such as DNA sequencing and single nucleotide polymorphism or comparative genomic hybridization arrays, enable researchers to accurately detect such lesions.[@R1]

Recently we reported a computational analysis of intragenic DNA breakpoints in glioblastoma (GBM), the most common adult tumor in the central nervous system.[@R2] Using a cohort of more than 500 samples, we identified an expected increase in DNA strand breaks near genes commonly targeted by copy number gain and losses in GBM, such as *EGFR* on 7p, *CDKN2A/B* on 9q, and *PTEN* on 10q. Less anticipated was the enrichment of DNA breakpoints on an 18 megabase region encompassing cytoband 12q14--15.

The 12q region, which we referred to as 12q14--15 breakpoint enriched region or BER, contains the well-known oncogenes murine double minute 2 (*MDM2)* and cyclin-dependent kinase 4 (*CDK4)*, which are frequently amplified in GBM (7.6% and 14%, respectively).[@R3] Detected in 24 of 493 (4.9%) GBMs, all BER samples showed a dense pattern of interspersed local copy number gains and losses. Among these small "copy number islands", *CDK4* and *MDM2* were almost always amplified simultaneously (87.5% of BERs). Interestingly, each DNA gain appeared at similar dosage levels, suggesting that they were conjunctly amplified. Using matched RNA sequencing (RNAseq) data we observed direct gene fusions among the BER-related amplicons in 7 of 9 RNAseq available BER cases. This finding raises the question whether the frequent breaks in this relatively small region represent a mechanism aimed at simultaneous amplification of the *CDK4* and *MDM2* oncogenes. In our data set, the 21 of 33 (64%) of GBM with dual amplification of *CDK4* and *MDM2* also displayed a BER pattern, and this percentage may represent a lower boundary due to a stringent statistical threshold.

Based on the pattern of revolving copy number gains and corroborating transcript fusions, we propose a hypothetical model that involves double minutes ([Fig. 1](#F1){ref-type="fig"}), an extrachromosomal circular structure formed by DNA end-to-end joining.[@R4] Using whole-genome sequencing data, more than 20 12q14--15 segments in a BER were shown to be connected and suggestive of a double minute-like structure.[@R3] Double minutes have been reported as a means to amplify the epithelial growth factor receptor gene (*EGFR*) in gliomas.^5^ We speculate that glioma cells can similarly leverage this structure to jointly amplify *CDK4* and *MDM2*. An unresolved issue is the mechanism by which this short DNA region is fragmented prior to the segments being joined.

![**Figure 1.** A double minute model to explain the 12q14--15 breakpoint enriched region (BER).](cc-12-3705-g1){#F1}

Our survey of intragenic breakpoints identified a second unanticipated outlier of breakpoint enrichment in chromosome 1p. In this instance, the increased breakage frequency was related to the gene FAS1-associated factor 1 (*FAF1*). Intragenic breakpoints in *FAF1*, which we found to lead to mRNA depletion, is an epiphenomenon of the focal deletion of the 5′ adjacent tumor suppressor gene *CDKN2C*. However, transfection experiments demonstrated a proapoptotic role for FAF1 in cell culture and tumor-sphere formation. Our results suggest that converging breakpoints in one gene may provide increased cellular fitness, and thereby lead to proliferative advantages.

In summary, our analysis revealed DNA breakpoints as a fingerprint of localized genome instability. In particular, we found a focal shattering pattern on 12q that was associated with adverse outcomes in a subset of glioblastoma patients.[@R2] Related to the pattern, we reported orchestrated amplification of *CDK4* and *MDM2*. Further studies are required to determine that the BER pattern relates to a synergistic interaction between the 2 oncogenes.
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